The global radiopharmaceuticals market was valued at USD 6.6 Bn in 2024 and is projected to reach USD 14.6 Bn by the end of 2035, expanding at a CAGR of 7.6% from 2025 to 2035. Growth is driven by the rising prevalence of cancer and cardiovascular diseases, increasing adoption of nuclear medicine in diagnostic imaging, and ongoing advancements in targeted radiotherapy. The radiopharmaceutical...